Digene fires Abbott to go with Roche in Europe
This article was originally published in Clinica
Executive Summary
Digene has terminated its marketing and distribution agreement with Abbott Laboratories for Digenes's human papllomavirus (HPV) test. At the same time, it is downgrading its agreement with Abbott for distribution of Digene's hepatitis B DNA tests to a non-exclusive agreement for the remainder of its term. The move cleared the way for Digene to sign a deal with Abbott's competitor, Roche, which it announced on the same day last week.